The National Home Infusion Association (NHIA) today announced growing bipartisan momentum for the Preserving Patient Access to Home Infusion Act, with ten new cosponsors signing onto the bill in the wake of NHIA’s Advocacy in Action Day.
NHIA is seeking public feedback on the draft Infusion Practice Standard: Pharmacist Documentation – Initial Assessment and Plan of Care. This standard was developed in response to a growing need for clear, consistent guidance on pharmacist documentation practices within the home and alternate-site.
The National Home Infusion Association (NHIA) today held its annual Advocacy in Action Day, during which association members and patients met with Members of Congress and their staff to advocate for a fix to the Medicare home infusion coverage gap. Over the course of the event, NHIA members held more than 130 meetings in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172 / S. 1058).
Registration is now open for the National Home Infusion Association’s 2026 Annual Conference (NHIA 2026), to be held April 18-22, 2026, at the Gaylord Rockies Resort and Convention Center in Denver, CO.
NHIA released a new white paper, “Trends in Home Enteral Nutrition—The Impacts of Competitive Bidding on Access and Quality,” which documents the declining payment structure for clinical services needed to support patients on home enteral nutrition.
NHIA submitted comments to the DME MAC medical directors regarding their proposed local coverage determination (LCD) for external infusion pumps (EIPs). DL33794 would expand Medicare Part B coverage for blinatumomab (Blimcyto®, Amgen) for certain indications.
The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was first introduced in the House of Representatives in September of 2023, and re-introduced on August 19, 2025 by Rep. Brian Fitzpatrick (PA-01). The bill mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit.
The National Home Infusion Association (NHIA) has released a white paper examining the economic challenges facing home parenteral nutrition (HPN) services. The report, “Ensuring Sustainable Access to Home Parenteral Nutrition (PN): The Cost Crisis and Path Forward,” documents cost trends and reimbursement patterns affecting this therapy.
The National Home Infusion Foundation’s Wellness Challenge is returning this September, and we’re excited to invite your organization to sponsor a team and make a meaningful impact on our industry!
The National Home Infusion Association (NHIA) and WeInfuse are pleased to announce the addition of WeInfuse to NHIA’s Future of Infusion Advisory Council (FIAC).
NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.
NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.
The National Home Infusion Foundation (NHIF) welcomes the 2025-2026 Board of Directors.
The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.
Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2025 Outstanding Abstract Achievement Award (OAAA) is Leslie Myers, PharmD, IgCP of CSI Pharmacy.
The National Home Infusion Association has announced the finalists for its 2025 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
The National Home Infusion Association (NHIA) today announced growing bipartisan momentum for the Preserving Patient Access to Home Infusion Act, with ten new cosponsors signing onto the bill in the wake of NHIA’s Advocacy in Action Day.
NHIA is seeking public feedback on the draft Infusion Practice Standard: Pharmacist Documentation – Initial Assessment and Plan of Care. This standard was developed in response to a growing need for clear, consistent guidance on pharmacist documentation practices within the home and alternate-site.
The National Home Infusion Association (NHIA) today held its annual Advocacy in Action Day, during which association members and patients met with Members of Congress and their staff to advocate for a fix to the Medicare home infusion coverage gap. Over the course of the event, NHIA members held more than 130 meetings in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172 / S. 1058).
Registration is now open for the National Home Infusion Association’s 2026 Annual Conference (NHIA 2026), to be held April 18-22, 2026, at the Gaylord Rockies Resort and Convention Center in Denver, CO.
NHIA released a new white paper, “Trends in Home Enteral Nutrition—The Impacts of Competitive Bidding on Access and Quality,” which documents the declining payment structure for clinical services needed to support patients on home enteral nutrition.
NHIA submitted comments to the DME MAC medical directors regarding their proposed local coverage determination (LCD) for external infusion pumps (EIPs). DL33794 would expand Medicare Part B coverage for blinatumomab (Blimcyto®, Amgen) for certain indications.
The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was first introduced in the House of Representatives in September of 2023, and re-introduced on August 19, 2025 by Rep. Brian Fitzpatrick (PA-01). The bill mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit.
The National Home Infusion Association (NHIA) has released a white paper examining the economic challenges facing home parenteral nutrition (HPN) services. The report, “Ensuring Sustainable Access to Home Parenteral Nutrition (PN): The Cost Crisis and Path Forward,” documents cost trends and reimbursement patterns affecting this therapy.
The National Home Infusion Foundation’s Wellness Challenge is returning this September, and we’re excited to invite your organization to sponsor a team and make a meaningful impact on our industry!
The National Home Infusion Association (NHIA) and WeInfuse are pleased to announce the addition of WeInfuse to NHIA’s Future of Infusion Advisory Council (FIAC).
NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.
NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.
The National Home Infusion Foundation (NHIF) welcomes the 2025-2026 Board of Directors.
The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.
Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2025 Outstanding Abstract Achievement Award (OAAA) is Leslie Myers, PharmD, IgCP of CSI Pharmacy.
The National Home Infusion Association has announced the finalists for its 2025 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
